约翰·霍普金斯·金梅尔癌症中心的研究显示,免疫信号预测免疫疗法的副作用。 Study from Johns Hopkins Kimmel Cancer Center reveals immune signatures predict immunotherapy side effects.

约翰·霍普金斯·金梅利癌症中心的一项研究表明,接受免疫疗法的癌症患者的特定免疫特征可以预测不良副作用。 A study from Johns Hopkins Kimmel Cancer Center reveals that specific immune signatures in cancer patients undergoing immunotherapy can predict adverse side effects. 研究人员发现,T细胞帮手2(TH2)和T细胞帮手17(TH17)的白血细胞增加,加上内分泌6(IL-6)水平上升,表明这些事件的风险较高。 Researchers found that increases in T-cell helper 2 (Th2) and T-cell helper 17 (Th17) white blood cells, along with rising interleukin-6 (IL-6) levels, indicate higher risks for these events. 调查结果旨在帮助肿瘤学家及早发现高风险患者,并通过有针对性的治疗改善治疗结果。 The findings aim to help oncologists identify high-risk patients early and improve treatment outcomes through targeted therapies.